🕵️ Nephros Inc ($NEPH)
SEC insider & ownership activity, last 12 months · CIK 1196298 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. No red-flag 8-Ks in the window.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| CD Holding Company, LLC | 5.7% | 13G | Sep 16, 2026 | filing ↗ | |
| Topline Capital Management, LLC | 5.6% | 13G | Nov 14, 2025 | filing ↗ | |
| Collin McBirney | 5.6% | 13G | Nov 14, 2025 | filing ↗ | |
| Topline Capital Partners, LP | 5.6% | 13G | Nov 14, 2025 | filing ↗ | |
| Charles E. Davidson | exited | 13D | Sep 14, 2026 | filing ↗ | |
| Wexford Capital LP | exited | 13D | Sep 14, 2026 | filing ↗ | |
| Wexford GP LLC | exited | 13D | Sep 14, 2026 | filing ↗ | |
| Joseph M. Jacobs | exited | 13D | Sep 14, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Aug 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 6, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 12, 2026 | filing ↗ |
| Earnings (2.02) | May 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 27, 2026 | filing ↗ |
| Material agreement (1.01) | Nov 21, 2025 | filing ↗ |
| Agreement terminated (1.02) | Nov 21, 2025 | filing ↗ |